High gene expression ratio of CD163/CCL3 in gliomas, as M2 and M1 macrophage markers, respectively, and PD-1+ CD4 T cells in the blood of tumor patients were associated with poor prognosis [75]. The gene discussed is CD163; the disease is central nervous system cancer.